<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
68788-8833-9
</NDCCode>
<PackageDescription>
1 TUBE, WITH APPLICATOR in 1 BOX (68788-8833-9) / 9900 mg in 1 TUBE, WITH APPLICATOR
</PackageDescription>
<NDC11Code>
68788-8833-09
</NDC11Code>
<ProductNDC>
68788-8833
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Lidopro Pain Relief
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Capsaicin And Lidocaine
</NonProprietaryName>
<DosageFormName>
OINTMENT
</DosageFormName>
<RouteName>
TRANSDERMAL
</RouteName>
<StartMarketingDate>
20250221
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M017
</ApplicationNumber>
<LabelerName>
Preferred Pharmaceuticals Inc.
</LabelerName>
<SubstanceName>
CAPSAICIN; LIDOCAINE HYDROCHLORIDE; MENTHOL, (+)-; METHYL SALICYLATE
</SubstanceName>
<StrengthNumber>
.0325; 4; 10; 27.5
</StrengthNumber>
<StrengthUnit>
mg/100mg; mg/100mg; mg/100mg; mg/100mg
</StrengthUnit>
<Pharm_Classes>
Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-02-25
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250221
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>